BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 34528528)

  • 1. Autoantibodies in the diagnosis, prognosis, and prediction of colorectal cancer.
    Niloofa R; De Zoysa MI; Seneviratne LS
    J Cancer Res Ther; 2021; 17(4):819-833. PubMed ID: 34528528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a multiplexed tumor-associated autoantibody-based blood test for the detection of colorectal cancer.
    Fan CW; Kuo YB; Lin GP; Chen SM; Chang SH; Li BA; Chan EC
    Clin Chim Acta; 2017 Dec; 475():157-163. PubMed ID: 29074220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Blood Autoantibodies in the Detection of Colorectal Cancer.
    Negm OH; Hamed MR; Schoen RE; Whelan RL; Steele RJ; Scholefield J; Dilnot EM; Shantha Kumara HM; Robertson JF; Sewell HF
    PLoS One; 2016; 11(7):e0156971. PubMed ID: 27383396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of tumor-associated autoantigens for the diagnosis of colorectal cancer in serum using high density protein microarrays.
    Babel I; Barderas R; Díaz-Uriarte R; Martínez-Torrecuadrada JL; Sánchez-Carbayo M; Casal JI
    Mol Cell Proteomics; 2009 Oct; 8(10):2382-95. PubMed ID: 19638618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood autoantibodies against tumor-associated antigens as biomarkers in early detection of colorectal cancer.
    Chen H; Werner S; Tao S; Zörnig I; Brenner H
    Cancer Lett; 2014 May; 346(2):178-87. PubMed ID: 24462820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Value of Serum p53 Antibody in the Diagnosis and Prognosis of Colorectal Cancer.
    Kunizaki M; Sawai T; Takeshita H; Tominaga T; Hidaka S; To K; Miyazaki T; Hamamoto R; Nanashima A; Nagayasu T
    Anticancer Res; 2016 Aug; 36(8):4171-5. PubMed ID: 27466527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a novel multiplex beads-based assay for autoantibody detection for colorectal cancer diagnosis.
    Villar-Vázquez R; Padilla G; Fernández-Aceñero MJ; Suárez A; Fuente E; Pastor C; Calero M; Barderas R; Casal JI
    Proteomics; 2016 Apr; 16(8):1280-90. PubMed ID: 26915739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiplexed monitoring of a novel autoantibody diagnostic signature of colorectal cancer using HaloTag technology-based electrochemical immunosensing platform.
    Garranzo-Asensio M; Guzmán-Aránguez A; Povedano E; Ruiz-Valdepeñas Montiel V; Poves C; Fernandez-Aceñero MJ; Montero-Calle A; Solís-Fernández G; Fernandez-Diez S; Camps J; Arenas M; Rodríguez-Tomàs E; Joven J; Sanchez-Martinez M; Rodriguez N; Dominguez G; Yáñez-Sedeño P; Pingarrón JM; Campuzano S; Barderas R
    Theranostics; 2020; 10(7):3022-3034. PubMed ID: 32194852
    [No Abstract]   [Full Text] [Related]  

  • 9. Prospective evaluation of 64 serum autoantibodies as biomarkers for early detection of colorectal cancer in a true screening setting.
    Chen H; Werner S; Butt J; Zörnig I; Knebel P; Michel A; Eichmüller SB; Jäger D; Waterboer T; Pawlita M; Brenner H
    Oncotarget; 2016 Mar; 7(13):16420-32. PubMed ID: 26909861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-p53 autoantibody in blood as a diagnostic biomarker for colorectal cancer: A meta-analysis.
    Liu S; Tan Q; Song Y; Shi Y; Han X
    Scand J Immunol; 2020 Feb; 91(2):e12829. PubMed ID: 31536647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiplexed VeraCode bead-based serological immunoassay for colorectal cancer.
    Ostendorff HP; Awad A; Braunschweiger KI; Liu Z; Wan Z; Rothschild KJ; Lim MJ
    J Immunol Methods; 2013 Dec; 400-401():58-69. PubMed ID: 24161315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of autoantibodies against Rabphilin-3A-like protein as a potential biomarker in patient's sera of colorectal cancer.
    Chen JS; Kuo YB; Chou YP; Chan CC; Fan CW; Chen KT; Huang YS; Chan EC
    Clin Chim Acta; 2011 Jul; 412(15-16):1417-22. PubMed ID: 21536019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of autoantibody signatures as biomarkers for early detection of colorectal carcinoma.
    Chang W; Wu L; Cao F; Liu Y; Ma L; Wang M; Zhao D; Li P; Zhang Q; Tan X; Yu Y; Lou Z; Zhao J; Zhang H; Fu C; Cao G
    Clin Cancer Res; 2011 Sep; 17(17):5715-24. PubMed ID: 21771877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic potential of zinc finger protein-specific autoantibodies and associated linear B-cell epitopes in colorectal cancer.
    O'Reilly JA; Fitzgerald J; Fitzgerald S; Kenny D; Kay EW; O'Kennedy R; Kijanka GS
    PLoS One; 2015; 10(4):e0123469. PubMed ID: 25875936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low positive rate of serum autoantibodies in colorectal cancer patients without systemic rheumatic diseases.
    Fernández-Suárez A; Muñoz-Colmenero A; Ocaña-Pérez E; Fatela-Cantillo D; Domínguez-Jiménez JL; Díaz-Iglesias JM
    Autoimmunity; 2016 Sep; 49(6):383-387. PubMed ID: 27424781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The presence of anti-GRP78 antibodies in the serum of patients with colorectal carcinoma: a potential biomarker for early cancer detection.
    Raiter A; Vilkin A; Gingold R; Levi Z; Halpern M; Niv Y; Hardy B
    Int J Biol Markers; 2014 Dec; 29(4):e431-5. PubMed ID: 24803280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-panel assay of serum autoantibodies in colorectal cancer.
    Ushigome M; Nabeya Y; Soda H; Takiguchi N; Kuwajima A; Tagawa M; Matsushita K; Koike J; Funahashi K; Shimada H
    Int J Clin Oncol; 2018 Oct; 23(5):917-923. PubMed ID: 29691673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibodies as biomarkers for colorectal cancer: A systematic review, meta-analysis, and bioinformatics analysis.
    Wang H; Li X; Zhou D; Huang J
    Int J Biol Markers; 2019 Dec; 34(4):334-347. PubMed ID: 31588830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum CCL20 combined with IL-17A as early diagnostic and prognostic biomarkers for human colorectal cancer.
    Wang D; Yuan W; Wang Y; Wu Q; Yang L; Li F; Chen X; Zhang Z; Yu W; Maimela NR; Cao L; Wang D; Wang J; Sun Z; Liu J; Zhang Y
    J Transl Med; 2019 Aug; 17(1):253. PubMed ID: 31387598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A specific autoantibody against a novel tumour-association antigen derived from human DNA-topoiomerase I is a potential biomarker for early diagnosis and favourable prognosis in patients with colorectal carcinoma.
    Zhao F; Cao M; Jiang XH; Xie K; Ye SR; Yie SM
    Biomarkers; 2020 Mar; 25(2):149-156. PubMed ID: 31922440
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.